Drugs / QIV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03615482 | Sep 2018 → Jun 2019 | pneumococcal infection | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03615482 ↗ |
| Modality | Vaccine | “seasonal inactivated quadrivalent influenza vaccine (QIV)” NCT03615482 ↗ |
| Route | Intramuscular | “a single 0.5 mL IM injection of QIV” NCT03615482 ↗ |